(NYSE: MCK) Mckesson's forecast annual revenue growth rate of 9.08% is forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 7.87%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.6%.
Mckesson's revenue in 2026 is $397,958,000,000.On average, 19 Wall Street analysts forecast MCK's revenue for 2027 to be $54,701,917,949,952, with the lowest MCK revenue forecast at $51,378,343,318,848, and the highest MCK revenue forecast at $57,989,603,756,448. On average, 16 Wall Street analysts forecast MCK's revenue for 2028 to be $58,995,593,232,576, with the lowest MCK revenue forecast at $54,617,034,142,944, and the highest MCK revenue forecast at $63,147,060,578,784.
In 2029, MCK is forecast to generate $63,239,416,120,608 in revenue, with the lowest revenue forecast at $60,620,266,848,960 and the highest revenue forecast at $66,516,812,980,800.